117 results on '"van Putten, Wim L.J."'
Search Results
2. Risk stratification of intermediate-risk acute myeloid leukemia: integrative analysis of a multitude of gene mutation and gene expression markers
3. Dose Escalation and Quality of Life in Patients With Localized Prostate Cancer Treated With Radiotherapy: Long-Term Results of the Dutch Randomized Dose-Escalation Trial (CKTO 96-10 Trial)
4. Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial
5. Postoperative radiotherapy for Stage 1 endometrial carcinoma: Long-term outcome of the randomized PORTEC trial with central pathology review
6. Acute and late complications after radiotherapy for prostate cancer: Results of a multicenter randomized trial comparing 68 Gy to 78 Gy
7. Dose-Response in Radiotherapy for Localized Prostate Cancer: Results of the Dutch Multicenter Randomized Phase III Trial Comparing 68 Gy of Radiotherapy With 78 Gy
8. Prognostic Index for Adult Patients With Acute Myeloid Leukemia in First Relapse
9. Outcome of High-Risk Stage IC, Grade 3, Compared With Stage I Endometrial Carcinoma Patients: The Postoperative Radiation Therapy in Endometrial Carcinoma Trial
10. Breast Cancer after Prophylactic Bilateral Mastectomy in Women with a BRCA1 or BRCA2 Mutation
11. Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients
12. Survival after relapse in patients with endometrial cancer: results from a randomized trial☆
13. Bone Marrow Transplantation versus Chemotherapy in Non-Hodgkin's Lymphoma
14. The morbidity of treatment for patients with stage I endometrial cancer: results from a randomized trial
15. Autonomous Proliferation Of Leukemic Cells In Vitro As A Determinant Of Prognosis In Adult Acute Myeloid Leukemia
16. Immediate versus delayed shoulder exercises after axillary lymph node dissection
17. Adjuvant portal liver infusion in colorectal cancer with 5-fluorouracil/heparin versus urokinase versus control: results of a prospective randomized clinical trial (colorectal adenocarcinoma trial I)
18. Acute morbidity reduction using 3DCRT for prostate carcinoma: a randomized study
19. Comparison of the clinical effectiveness of the 433 MHz lucite cone applicator with that of a conventional waveguide applicator in applications of superficial hyperthermia
20. High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study
21. Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome
22. 90Yttrium-Ibritumomab Tiuxetan Consolidation of First Remission in Advanced-Stage Follicular Non-Hodgkin Lymphoma: Updated Results After a Median Follow-Up of 7.3 Years From the International, Randomized, Phase III First-Line Indolent Trial
23. Comparative Analysis of the Value of Allogeneic Hematopoietic Stem-Cell Transplantation in Acute Myeloid Leukemia With Monosomal Karyotype Versus Other Cytogenetic Risk Categories
24. Long-Term Outcome and Quality of Life of Patients With Endometrial Carcinoma Treated With or Without Pelvic Radiotherapy in the Post Operative Radiation Therapy in Endometrial Carcinoma 1 (PORTEC-1) Trial
25. 90Y-Ibritumomab Tiuxetan (Zevalin®) Consolidation of First Remission In Advanced-Stage Follicular Non-Hodgkin's Lymphoma: Updated Results After a Median Follow-up of 66.2 Months From the International, Randomized, Phase III First-Line Indolent Trial (FIT) In 414 Patients
26. High Prognostic Impact of Flowcytometric Minimal Residual Disease Detection In Acute Myeloid Leukemia: Prospective Data From the HOVON/SAKK 42a Study
27. Update of Dutch Multicenter Dose-Escalation Trial of Radiotherapy for Localized Prostate Cancer
28. Monosomal Karyotype in Acute Myeloid Leukemia: A Better Indicator of Poor Prognosis Than a Complex Karyotype
29. Dose–Volume Parameters of the Corpora Cavernosa Do Not Correlate With Erectile Dysfunction After External Beam Radiotherapy for Prostate Cancer: Results From a Dose–Escalation Trial
30. Sexual Function After Three-Dimensional Conformal Radiotherapy for Prostate Cancer: Results From a Dose-Escalation Trial
31. Daunorubicin and Cytarabine Compared with Daunorubicin, Cytarabine and the MDR1 Reversal Agent PSC-833 in Elderly Patients with Acute Myelogenous Leukemia.
32. Clinical Useful Prognostic Index for Adult Patients with Acute Myeloid Leukemia in First Relapse.
33. Cytogenetic clonality analysis of megakaryocytes in myelodysplastic syndrome by dual-color fluorescence in situ hybridization and confocal laser scanning microscopy
34. Prognostic value of CD44 variant expression in primary breast cancer
35. Heterogeneous X Inactivation in Trophoblastic Cells of Human Full-Term Female Placentas
36. Ischemic heart disease after mantlefield irradiation for Hodgkin's disease in long-term follow-up
37. Muscle invasive bladder cancer treated by transurethral resection, followed by external beam radiation and interstitial iridium-192
38. DNA-synthesis enzyme activity: A biological tool useful for predicting anti-metabolic drug sensitivity in breast cancer?
39. The impact of abn(17p) and monosomy −5/del(5q) on the prognostic value of the monosomal karyotype in acute myeloid leukemia
40. Biopsy of nonpalpable cervical lymph nodes: Selection criteria for ultrasound-guided biopsy in patients with head and neck squamous cell carcinoma
41. 143 Muscle invasive bladder cancer treated by transurethral resection, followed by external beam radiation and interstitial iridium-192
42. Oncogene amplification and prognosis in breast cancer: Relationship with systemic treatment
43. Comparison of CHOP Chemotherapy with Autologous Bone Marrow Transplantation for Slowly Responding Patients with Aggressive Non-Hodgkin's Lymphoma
44. Dose, fractionation and overall treatment time in radiation therapy — the effects on local control for cancer of the larynx
45. Anaplastic carcinoma of the thyroid gland treated by radiation therapy
46. Comparison of four filters for leukocyte depletion of single donor plateletapheresis products
47. The prognostic value of epidermal growth factor receptors, determined by both immunohistochemistry and ligand binding assays, in primary epithelial ovarian cancer: a pilot study
48. Tumor and normal tissue response to interstitial photodynamic therapy of the rat r-1 rhabdomyosarcoma
49. Double CEBPAmutations, but not single CEBPAmutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome
50. Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+NHL: a prospective randomized HOVON trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.